Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Saira Kalia, MD

Articles by Saira Kalia, MD

If it does not count, it is not counted.

Maternal Mental Health Needs to Count

BySaira Kalia, MD

June 22nd 2022

If it does not count, it is not counted.

Latest Updated Articles

Trending on Psychiatric Times

Asynchronous ADHD Assessment: New Tools for Better Evaluation

Women Are Diagnosed With ADHD 5 Years Later Than Men

Seltorexant Well-Tolerated in Adolescents as an Adjunct Treatment for Major Depressive Disorder

New Data on Lumateperone for Prevention of Relapse in Schizophrenia

Phase 3 Data Support CT-155 as a Novel Digital Therapeutic for Negative Symptoms in Schizophrenia at ECNP

© 2025 MJH Life Sciences^®

All rights reserved.